-
News Agency News Aggregator Journalist/Editor Broking House Others
BAFNAPHARM - Book Closure For The Purpose Of Annual General Meeting
BAFNAPHARM - Fixes Book Closure for AGM
Bafna Pharmaceuticals loss decreased by 99.30% in (Q4) FY 2019-20
BAFNAPHARM - Announcement under Regulation 30 (LODR)-Resignation of Director
BAFNAPHARM - Financial Result For The Year Ending 31St March 2020
BAFNAPHARM - Outcome Of Board Meeting
BAFNAPHARM - Board Meeting Intimation for Board Meeting For Audited Result And Other Business Matters (General)
BAFNAPHARM - Certificate From Practicing Company Secretary For The Half Year Ended 31St March 2020
BAFNAPHARM - Shareholding for the Period Ended March 31, 2020
BAFNAPHARM - Statement Of Investor Complaints For The Quarter Ended March 2020
BAFNAPHARM - Compliance Certificate For The Half Year Ended 31St March 2020<BR> <BR>
Stocks showing buyers’ interest Ruchi Soya Industries, Geekay Wires and Bafna Pharmaceuticals witnessed strong buying interest from market participants as they scaled their fresh 52-week highs on Friday signalling bullish sentiment.
Stocks showing buyers’ interest Ruchi Soya Industries, Bafna Pharmaceuticals and Geekay Wires witnessed strong buying interest from market participants as they scaled their fresh 52-week highs on Wednesday signalling bullish sentiment.
Stocks showing buyers’ interest Ruchi Soya Inds, Geekay Wires and Bafna Pharma witnessed strong buying interest from market participants as they scaled their fresh 52-week highs on Wednesday signalling bullish sentiment.
Stocks showing buyers’ interest Shares of GSK Cons Health, Bafna Pharma, Geekay Wires and Ruchi Soya witnessed strong buying interest from market participants as they scaled their fresh 52-week highs on Tuesday, signalling bullish sentiment.
BAFNAPHARM - Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
BAFNAPHARM - Annoucement Under Regulation 30 Of LODR
BAFNAPHARM - Discrepancy In Corporate Announcement (Board Meeting Notice)
BAFNAPHARM - Board Meeting Intimation for Quarterly Result
BAFNAPHARM - Statement Of Investor Complaints For The Quarter Ended December 2019
-
Connect with us on social media
